Director's Dealing • Mar 13, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 5941A
BAE SYSTEMS PLC
13 March 2025
BAE Systems plc
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Tom Arseneault
G
Reason for the notification
a)
Position/status
President and Chief Executive Officer of BAE Systems, Inc.
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
BAE Systems plc
b)
LEI
8SVCSVKSGDWMW2QHOH83
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 2.5p each in BAE Systems plc
GB0002634946
b)
Nature of the transaction
Exercise of 267,026 options under the BAE Systems Long Term Incentive Plan (LTIP), and the subsequent sale of 155,717 shares including those to satisfy tax liabilities.
c)
Price(s) and volume(s)
| Price | Volume(s) | |
| Acquisition of shares on exercise of share option | £6.49 | 267,026 |
| Shares retained to cover the costs of exercise | £15.569355 | 111,309 |
| Sale of shares including those to satisfy tax liabilities | £15.569355 | 155,717 |
d)
Aggregated information
- Aggregated volume
- Price
Exercise
Volume: 267,026
Price GBP: £1,732,998.74
Shares retained to cover the costs of exercise
Volume: 111,309
Price GBP: £1,733,009.34
Sale of shares, including those to satisfy tax liabilities
Volume: 155,717
Price GBP: £2,424,413.25
e)
Date of the transaction
2025-03-12
f)
Place of the transaction
XLON - London Stock Exchange
13 March 2025
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUORURVBUOAAR
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.